Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 241 of the 242 references it cites were found in a registry or an index; none of the 155 sources its claims cite is checked for support yet.
Abstract
This paper discusses the mechanisms of S. aureus drug resistance including: (1) introduction. (2) resistance to beta-lactam antibiotics, with particular emphasis on the mec genes found in the Staphylococcaceae family, the structure and occurrence of SCCmec cassettes, as well as differences in the presence of some virulence genes and its expression in major epidemiological types and clones of HA-MRSA, CA-MRSA, and LA-MRSA strains. Other mechanisms of resistance to beta-lactam antibiotics will also be discussed, such as mutations in the gdpP gene, BORSA or MODSA phenotypes, as well as resistance to ceftobiprole and ceftaroline. (3) Resistance to glycopeptides (VRSA, VISA, hVISA strains, vancomycin tolerance). (4) Resistance to oxazolidinones (mutational and enzymatic resistance to linezolid). (5) Resistance to MLS-B (macrolides, lincosamides, ketolides, and streptogramin B). (6) Aminoglycosides and spectinomicin, including resistance genes, their regulation and localization (plasmids, transposons, class I integrons, SCCmec), and types and spectrum of enzymes that inactivate aminoglycosides. (7). Fluoroquinolones (8) Tetracyclines, including the mechanisms of active protection of the drug target site and active efflux of the drug from the bacterial cell. (9) Mupirocin. (10) Fusidic acid. (11) Daptomycin. (12) Resistance to other antibiotics and chemioterapeutics (e.g., streptogramins A, quinupristin/dalfopristin, chloramphenicol, rifampicin, fosfomycin, trimethoprim) (13) Molecular epidemiology of MRSA.
Overview
CoChat Summary
TL;DR
This review summarizes molecular mechanisms of drug resistance in *Staphylococcus aureus*, covering beta-lactams, glycopeptides, oxazolidinones, MLS-B, aminoglycosides, fluoroquinolones, tetracyclines, mupirocin, fusidic acid, daptomycin, and other agents. It emphasizes SCC*mec*/*mec*-mediated methicillin resistance, VanA-mediated glycopeptide resistance, and mobile genetic elements as drivers of multidrug resistance.
Key findings
- Methicillin resistance is chiefly mediated by PBP2A encoded by *mec* genes within SCC*mec* cassettes; 14 major SCC*mec* types have been described, ranging from 21 to 82 thousand nucleotides, with *mecA*, *mecC*, and other *mec* variants distributed across staphylococci.
- Beta-lactam resistance also involves beta-lactamases (*blaZ*) and rare PBP mutations; a *mecA*-negative CRB strain had ceftobiprole MIC = 128 mg/L, ceftriaxone MIC = 256 mg/L, cefazolin MIC > 256 mg/L, nafcillin MIC = 128 mg/L, ampicillin MIC = 256 mg/L, and cefoxitin MIC = 8 mg/L.
- Glycopeptide resistance via the VanA operon in Tn*1546* confers vancomycin MIC 64–1024 mg/L and teicoplanin MIC 16–512 mg/L; only about a dozen VRSA strains with VanA have been described. In 187 MRSA strains from 41 Spanish hospitals, vancomycin tolerance was 9.6% and teicoplanin tolerance 21.9%.
- Aminoglycoside resistance commonly involves AAC(6′)-Ie/APH(2″)-Ia, the only enzyme known in *S. aureus* to determine gentamicin resistance; gentamicin MICs ranged from 8 mg/L to >1024 mg/L (MIC50 128 mg/L, MIC90 512 mg/L), and tobramycin MICs ranged from 8 to 256 mg/L (MIC50 32 mg/L, MIC90 64 mg/L).
Methods
- Design: narrative review of published literature on molecular resistance mechanisms in *S. aureus*; no systematic review protocol or primary experimental study is described.
- Data or sample: Not stated in the paper; the text cites clinical isolates, strains, plasmids, transposons, integrons, and SCC*mec* elements from prior studies.
- Main analysis: descriptive synthesis organized by antibiotic class and molecular epidemiology, including referenced tables and figures on SCC*mec* types, *mec*/*ccr* complexes, and MRSA clones.
Limitations
- The paper states no limitations section.
- Evident: as a narrative review, it lacks systematic search, inclusion criteria, and formal risk-of-bias assessment.
- Evident: it presents no new primary data and relies on previously published studies; several tables and figures are referenced but not included in the provided text, limiting verification of clone and SCC*mec* details.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 6 Not valid · 95 Not checked · 5 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“In 2006, the first class I integrons, previously described in Gram-negative bacteria, were detected in staphylococci, initially found in coagulase-negative staphylococci and later in S. aureus.”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [8] Shi L. Zheng M. Xiao Z. Asakura M. Su J. Li L. Yamasaki S. Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China Microbiol. Immunol. 2006 50 463 467 10.1111/j.1348-0421.2006.tb03815.x 16785718 source
- Not checked yetcites [9] Xu Z. Li L. Alam M.J. Zhang L. Yamasaki S. Shi L. First confirmation of integron-bearing methicillin-resistant Staphylococcus aureus Curr. Microbiol. 2008 57 264 268 10.1007/s00284-008-9187-8 18594909 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“The cassette genes functioning in these integrons that determine resistance to streptomycin (aadA2, aadA5), chloramphenicol (cmlA1) and trimethoprim (dfrA12, dfr17) have also been described [8,9].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [8] Shi L. Zheng M. Xiao Z. Asakura M. Su J. Li L. Yamasaki S. Unnoticed spread of class 1 integrons in gram-positive clinical strains isolated in Guangzhou, China Microbiol. Immunol. 2006 50 463 467 10.1111/j.1348-0421.2006.tb03815.x 16785718 source
- Not checked yetcites [9] Xu Z. Li L. Alam M.J. Zhang L. Yamasaki S. Shi L. First confirmation of integron-bearing methicillin-resistant Staphylococcus aureus Curr. Microbiol. 2008 57 264 268 10.1007/s00284-008-9187-8 18594909 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, the mere presence of a pathogenicity factor gene does not always equate to its expression, which is subject to one or more regulatory systems present in the bacterial cell, such as the Agr/Sar system [10]”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 1. Introduction
What the sources say
- Not checked yetcites [10] Butrico C.E. Cassat J.E. Quorum sensing and toxin production in Staphylococcus aureus osteomyelitis: Pathogenesis and paradox Toxins 2020 12 516 10.3390/toxins12080516 PMC7471978 32806558 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The mecA gene has been detected in S. aureus, S. pseudintermedius, Mammallicoccus fleuretti (former name Staphylococcus fleuretti), Mammallicoccus vitulinus (former name Staphylococcus vitulinus), Mammallicoccus sciuri (former name Staphylococcus sciuri) and in many other species of the genus Staphylococcus currently comprising 64 species [21].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 2. Resistance to Beta-Lactam Antibiotics > 2.2. PBP2A Synthesis (Methicillin-Resistance)
What the sources say
- Not checked yetcites [21] Taxonomy Browser (Staphylococcus) Available online: https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi (accessed on 3 February 2022)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Single strains of the so-called BORSA (borderline oxacillin-resistant S. aureus) have been described, in which the synthesized beta-lactamase had an extended spectrum and conditioned an oxacillin MIC of 4–8 mg/L [15].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 2. Resistance to Beta-Lactam Antibiotics > 2.1. Synthesis of Beta-Lactamases
What the sources say
- Not checked yetcites [15] Balslev U. Bremmelgaard A. Svejgaard E. Havstreym J. Westh H. An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit Microb. Drug Resist. 2005 11 78 81 10.1089/mdr.2005.11.78 15770100 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
57 more claims
Create a free account to see all 106 claims and to verify the 155 references still open.
- It may state two separate claims as one. 35
- Probably not a substantial claim. 15
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In MRSA, PBP2a maintains transpeptidase activity even under β-lactam exposure, enabling cross-linking of pentaglycan bridges between peptidoglycan chains [9,198].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“Resistance extends to all β-lactams except ceftobiprole and ceftaroline, which retain activity against PBP2a [9,203].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“Constitutive expression occurs in strains with ΔmecR1-mecA deletions [9,202].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
In the citing paper
“The mecA gene, located on the staphylococcal chromosomal cassette mec (SCCmec), produces PBP2a (also termed PBP2′), a 668-amino-acid protein that replaces the transpeptidase function of native PBPs inhibited by β-lactams [9,195,197].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 12. Other Antibiotics > 12.3. Resistance to Chloramphenicol
“A mutation in the rpoB gene (A1345G; substitution in RpoB protein D449N) was also described, conditioning the resistance of S. aureus strain to chloramphenicol (MIC-128 mg/L) and intermediate to oxazolidinones [94].”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 4. Resistance to Oxazolidinones
“A mutation in the rpoB gene (A1345G; substitution in the RpoB protein D449N) was also described, which determines the resistance of S. aureus strain to linezolid (MIC = 8 mg/L) and tedizolid (MIC = 4 mg/L), chloramphenicol (MIC-128 mg/L), medium sensitivity to quinupristin/dalphopristin (MIC-2 mg/L) [94].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 5. Resistance to Macrolides, Lincosamides, Ketolides and Streptogramins B
“VgbA, VgbB, inactivating streptogramin B lyases”
§ Molecular Mechanisms of Drug Resistance in Staphylococcus aureus > 12. Other Antibiotics > 12.1. Resistance to Streptogramins A and Quinupristin-Dalfopristin
“Resistance to streptogramins A in S. aureus may result from the production of enzymes that inactivate streptogramins A such as Vat acetyltransferases encoded by the plasmid genes vatA [179], vatB located in the Tn5406 transposon [180,181], vatC [130], vatD, vatE [130] or Vgb lyases encoded by the vgb(A) and vgb(B) genes [131].”
Citations
Cites
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,637
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Oliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Kondo, Y., Ito, T., Ma, X. X., Watanabe, S., Kreiswirth, B. N., Etienne, J., & Hiramatsu, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-06 · Cited by 965
Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., & Hiramatsu, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1323-1336.2001 · Cited by 963
García-Álvarez, L., Holden, M. T., Lindsay, H., Webb, C. R., Brown, D. F., Curran, M. D., Walpole, E., Brooks, K., Pickard, D. J., Teale, C., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70126-8 · Cited by 939
Research works printed but not linked: 1
- Taxonomy Browser (Staphylococcus) Available online: https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi (accessed on 3 February 2022)
Cited by
Items 301–400 of 412
Tran, B. N., Nguyen, V. T. A., & Nguyen, T. T. H. (2025) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-90197-3_79
Lalngaihmanawmi Lalngaihmanawmi, L., Lalthanpuii, P. B., Tlau, L., Lalawmpuii, L., Lalrosangpuii Lalrosangpuii, L., Lalnundanga Lalnundanga, L., & Lalchhandama, K. (2025) · Pharmacognosy Research · doi:10.5530/pres.20252145
Nosocomial infections as a growing therapeutic problem
Trześniewska-Ofiara, Z., Mendrycka, M., & Woźniak-Kosek, A. (2025) · Biuletyn Głównej Biblioteki Lekarskiej · doi:10.2478/bgbl-2025-0010
Salman, S. A. K., & Muhana, B. M. M. A. (2025) · Open Veterinary Journal · doi:10.5455/ovj.2025.v15.i6.27
Bezerra, T. C., Borges, C. E. A., Henrique, J. D. S., dos Santos, L. B., da Silva, D. G. T., dos Santos, R. N., Almeida, É. R. D. M., Silva, R. D. A., Correia, H. F. D. B., & Filho, V. D. M. S. (2025) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-284-0043-0/669-679
Kadyrova, I., Bakenova, A. A., Lavrinenko, A. V., Belyaev, I. A., Atazhanova, G. A., & Levaya, Y. К. (2025) · Medicine and ecology · doi:10.59598/me-2305-6053-2025-115-2-128-136
Jaiswal, R., Verma, A., Venkatesh, V., Garg, A., & Tripathi, A. (2025) · Journal of Laboratory Physicians · doi:10.25259/jlp_39_2025
Abdullahi, I. N., Lozano, C., & Torres, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33351-4.00013-1
Shamim, S. (2025) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps.2025.38.5.reg.13901.1
Clinical Manifestation and Antimicrobial Resistance Profile of Staphylococcal Mastitis in Sheep
Sharma, D. K., SONAWANE, G. G., Pandian, S. J., & Kumar, J. (2025) · Indian Journal of Small Ruminants (The) · doi:10.5958/0973-9718.2025.00025.x
Obturator internus abscess and superior ramus osteomyelitis: A case report in a pediatric patient
Hseinat, L. A., Othman, A. K., Saaideh, M. A. A., Al-Qudah, O. M., Khawaled, B. O. A., Khattab, K., Al-Tarawneh, O. R., Alkhraisha, F., & Khlaifat, A. (2025) · Radiology Case Reports · doi:10.1016/j.radcr.2025.09.013
Chen, S., Yu-xia, W., Liu, Y., Cheng, Q. H., Yao, Z., & Ye, X. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00792-25
Antimicrobial Activity of Aquipseudomonas alcaligenes Strain
Алексеевна, М. И., Khramtsova, E. V., Makarova, M. O., & Efremenkova, O. V. (2025) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/02352990-2025-70-7-8-4-9
dos Santos, M. C., de Oliveira, L. E. L., & Antón, A. R. S. (2025) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v24i3.70895
Tsobeng, O. D., Mbaveng, A. T., Kengne, M. F., Dadjo, B. S. T., & Kuete, V. (2025) · BioMed Research International · doi:10.1155/bmri/8076503
de Melo, I. K., Santos, C. S., Alves, N. D., Araújo, G. L., Clarindo, A. M., Pimenta, A. S., Leite, D. P. D. S. B. M., Mota, R. A., & Feijó, F. M. C. (2025) · Microorganisms · doi:10.3390/microorganisms13122771
Fluorogenic Substrate for Monitoring Activity of Muralytic Enzymes
Simon, M., Mogg, A. L. B., Klein, C. F., Hohl, K. M., Gomez, C., & Williams, S. J. (2025) · ACS Omega · doi:10.1021/acsomega.5c07632
In-silico docking of Ibezapolstat (ACX-362E) on S.aureus and M.genitalium DNA polymerasesPreprint
Velan (2025) · Research Square · doi:10.21203/rs.3.rs-8350083/v1
Resistencia a macrólidos en Staphylococcus de pacientes con COVID-19 en Santander
Angarita, M. J. S., Guerrero, M. Y. A., Parada-Diaz, A. J., Granados, N. A. B., Vargas, N. C. A., & Trejos-Suárez, J. (2025) · Revista CUIDARTE · doi:10.15649/cuidarte.4924
Yue, Y., Chen, K., Sun, C., Ahmed, S., & Ojha, S. C. (2024) · Figshare · doi:10.6084/m9.figshare.26632540
Oliveira, M. J. F. D. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/enhz-3v84
Yue, Y., Chen, K., Sun, C., Ahmed, S., & Ojha, S. C. (2024) · Figshare · doi:10.6084/m9.figshare.26632543
Yue, Y., Chen, K., Sun, C., Ahmed, S., & Ojha, S. C. (2024) · Figshare · doi:10.6084/m9.figshare.26632546
Wu, J., Huang, Y., Ding, X., Kang, L., Wang, X., Li, D., Cheng, W., Liu, G., Xue, J., & Ding, S. (2023) · Figshare · doi:10.6084/m9.figshare.23733109
Drivers of Staphylococcus aureus dynamics and survival in recreational waters
Steadmon, M. (2024) · ScholarSpace (University of Hawaii at Manoa) · Cited by 3
Raposo, M. C. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tavares, A. R. D. O. M. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Opredelitev kliničnih izolatov Staphylococcus argenteus pri bolnikih iz Osrednjeslovenske regije
Petek, L. (2024) · Repository of the University of Ljubljana (University of Ljubljana)
Inhibition of Growth and Biofilm Formation in Staphylococcus aureus by LLY-507
Tang, Y., Xu, Z., Li, C., Zhang, J., Zheng, J., Wen, Z., Yu, Z., Chen, Z., Han, S., Li, P., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c10668
Bezzi, A., Antri, K., Bachtarzi, M. A., Martins-Simões, P., Youenou, B., Gourari, S., Amhis, W., Natèche, F., & Tristan, A. (2026) · Journal of Applied Microbiology · doi:10.1093/jambio/lxag002
Sion, A., Martin, M. J., Bonhomme, M., Josse, J., Valour, F., Laurent, F. J., & Dupieux, C. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02461-25
Alvarado, Y. A. P., & Martinez-Guzman, M. A. (2026) · Ciencia y Frontera · doi:10.61865/j.cyfsld.2025.at21-tkd7
Li, H., Chen, S., Kou, X., Tian, Y., Wu, C., Liu, H., & Qiu, J. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04198-2
Esfeh, K. K., Dadgar, M., Dargahi, Z., Khaleghjoo, A., Ghasemi, E., Absalan, F., Barzegari, E., & Jamalan, M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-025-11391-5
许, 丹. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.162490
Interpréter un antibiogramme en pratique clinique à l’hôpital
Grandvincent, R., Demeule, C., Amoureux, L., & Blot, M. (2026) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2025.12.006
Computational approaches for QSAR-based prediction of MRSA antimicrobial activity
Laref, N., & Belkheir, K. (2026) · Journal of Taibah University for Science · doi:10.1080/16583655.2026.2629735
Voelker, T. L., Kannan, S., & Robertson, G. A. (2026) · Biophysical Journal · doi:10.1016/j.bpj.2025.11.1081
Balkrishna, A., Kharayat, B., Sengupta, S., Goswami, S., Tomer, M., Kabdwal, M., Gupta, L., Lochab, S., Haldar, S., & Varshney, A. (2026) · Journal of Applied Microbiology · doi:10.1093/jambio/lxag062
Vancomycin-Resistant Clinical Strains of Enterococcus spp. and Staphylococcus aureus
Lebedkova, A. A., Khokhlova, O. E., Коломбет, Л. В., & Kartsev, N. N. (2026) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2025-70-11-12-75-91
Bayraktar, H. S., Köksal, F., Duran, N., Kandemir, T., Baykara, B., Gökmen, T., & OCAL, M. M. (2026) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.21412 · Cited by 1
Triazine-Based Brominated COFs Capped by Nanoceria with Improved Antibacterial Activity
Ajgalle, A., & Mahapatra, C. (2026) · Emergent Materials · doi:10.1007/s42247-026-01349-z
Al-Abayechi, A.-H. A. Y., Abood, M. S., Karahan, Z. C., & AL-Khairo, M. Y. Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11726-w
Contarin, R. (2024) · theses.fr (ABES) · doi:10.70675/1434ee2bz3ff7z40c5zacf1zc316fcf78c21 · Cited by 1
du Québec, C. S. L. I. N., Boulais, A., Bolduc, M., & Moisan, D. (2026) · doi:10.64490/uedc2332
Banerjee, R., Dwivedi, A., & Toppo, A. J. (2026) · International Journal of Novel Research and Development · doi:10.56975/ijnrd.v11i4.323776
From Penicillin to Last-Resort Drugs: The Co-Evolution of Staphylococcus and Antibiotic Resistance
Singh, S., Singh, M., & Mukhopadhyay, K. (2026) · Infectious diseases · doi:10.5772/intechopen.1014908
Lakhani, S., & Thakor, P. (2026) · ChemistrySelect · doi:10.1002/slct.73343
Damascena, E. C. G., Santos, E. M. S., Carvalho, C. M. C., Aguilar, C. M., de Souza, C. N., da Fonseca, F. S. A., de Oliveira, I. P., Souto, A. F. D. N., Santos, H. O., & de Almeida, A. C. (2026) · International Journal of One Health · doi:10.14202/ijoh.2026.106-119
Boucherabine, S., Giddey, A. D., Nassar, R., Mohamed, L., Verma, S., Soares, N. C., & Senok, A. C. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1798070
Farias, A. B., Sisco, M. C., Costa, M. D. O. C. E., Pérez‐Rueda, E., & Nicolás, M. (2026) · ACS Omega · doi:10.1021/acsomega.6c00305
Rosado, P. C., Pinheiro, P. F., Marques, M. M., & Justino, G. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.15.725322
The Role of Selected Bacteria in Breast Cancer Initiation and Development
Gebretsadik, G., Islam, S., Szpendyk, J., Thomas, V. D., & Furuta, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104585
Zhou, F., Gu, X., Lin, M., Dai, Y., Li, Y., Jiang, M., Yangzong, B., Wang, Y., Sun, X., & Wang, L. (2026) · International Microbiology · doi:10.1007/s10123-026-00838-9
MECHANISMS AND CLINICAL IMPACT OF ANTIMICROBIAL RESISTANCE IN INFECTIVE ENDOCARDITIS
Srinivas, S., Saravanan, S., & Kindo, A. J. (2026) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/0503795
Drug repurposing: a dual-mechanism antibiotic combats MRSA and its high resistant phenotypes
She, P., Xiao, D., Huang, G., Guo, S., Liu, Y., Li, M., Lu, L. Z.-B., Hong, Y., & Wu, Y. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1851763
Antimicrobial Resistance Response Perspectives in Africa
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8073-8
Allam, T. A., Abdel-Kader, F., & Kadry, M. (2026) · BMC Veterinary Research · doi:10.1186/s12917-026-05591-9
Giuliano, S., Cojutti, P. G., Bulfoni, M., Cotrufo, M., Curcio, F., Gualandi, N., Lombardo, C., Moreal, C., Pea, F., Tascini, C., et al. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2026.107877
Deng, J.-T., Kong, W.-J., Lu, P.-H., Yu, L., Zhou, Q., Jin, J., & Nie, X.-R. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13704-w
Development of Reproducible Metagenomic Approaches for Skin and Wound Microbiome Analysis
Freiheit, M. (2026) · Repository@Hull (Worktribe) (University of Hull) · doi:10.5281/zenodo.17083748
Tuama, R. H., Ghannawi, L. A., Khalef, J. A., Atta, S. E., Shakir, O. Y., Thamer, M. A., & Abdulwahid, H. I. (2026) · Studia Biologica · doi:10.30970/sbi.2002.881
Peng, C., Lai, L., Zhang, C., Hu, M., Qi, Y., Liang, F., Chen, Z., Wang, S., & Huang, X. (2026) · Microorganisms · doi:10.3390/microorganisms14061310
Ghafoor, M., Saqib, M., Ashfaq, K., & Rehman, S. U. (2026) · Polish Journal of Veterinary Sciences · doi:10.24425/pjvs.2026.1277
Belém, K. S. T. G., Rocha, J. E., Bento, A. J. D. M., Dias, J. M. L., Coutinho, H. D. M., Pinto, F. D. C. L., de Menezes, R. R. P. P. B., da Silva, M. E., Marinho, E. S., Marinho, M. M., et al. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05007-0
Naik, S. S., & Pereira, F. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02364-0
Prakash, E. A., Kilcoyne, E., Tansey, D., & Walsh, F. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00044-26
Total Synthesis and Antibacterial Evaluation of (−)- and (+)- epi -Perrottetinene
Kumar, V., Gangwar, A., Khajuria, S., Saini, S., Samad, M., Singh, V. P., Sharma, R., & Singh, P. P. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00166
Liang, Y., Tian, M., Zhang, H., Guo, Y., Lu, J., Zhao, Y., Zhao, T., & Zhang, H. (2026) · Microorganisms · doi:10.3390/microorganisms14081635
Santos, P. R. D. O., das Neves, M. R. M., & de Brito, D. F. (2026) · Research Society and Development · doi:10.33448/rsd-v15i7.51459
Javidmehr, S., Mortazavi, S. J., Rastegar, M., Moradi, M., Ebrahimian, M., & Siavashi, B. (2026) · The Journal of Arthroplasty · doi:10.1016/j.arth.2026.07.042
Liu, Y., & Wang, B. (2026) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.42.8.13678
Kalliat, S. R., Valdes-Pena, M. A., & Pierce, J. G. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00283
Ключка, І. В. (2024) · Institutional Repository of National University of Food Technologies
Antimicrobial Resistance in Major Gram-Positive Pathogens: Beyond the Vancomycin Border
Papageorgiou, D., & Akinosoglou, K. (2026) · Antibiotics · doi:10.3390/antibiotics15080780 · Cited by 1
Bogaerts, B., Kowalewicz, C., Keersmaecker, S. C. J. D., Roosens, N. H. C., Vanneste, K., & Boland, C. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1894809
Singhal, L., Kumar, N., Sharma, C. S., Akhter, M., & Shrivastava, A. (2026) · Discover Chemistry. · doi:10.1007/s44371-026-00919-8
Mancuso, G., Mancusi, A., Cosentino, M. G., Cello, S. D., Malagrinò, M. C., Mungo, F., Palermo, P., Casbarra, M. A., Dini, I., & Proroga, Y. T. R. (2026) · International Journal of Microbiology · doi:10.1155/ijm/9978007
Genetic architecture and functional dynamics of integrons in Staphylococcus aureus resistance
Musini, A., Owais, M., & Joshika, R. (2026) · Brazilian Journal of Microbiology · doi:10.1007/s42770-026-02019-2
Ajagbe, J. M., Ali, H. B., Kumurya, A. S., Bitet, E. D., Bunza, N. M., & Ega, B. (2026) · Research Square · doi:10.21203/rs.3.rs-10693055/v1
Ade-Yusuf, R. O., Ahmed, A. O., Adeyemo, I. A., Isola, T. O., Ghali-Mohammed, I., & Odetokun, I. A. (2026) · FUDMA Journal of Sciences · doi:10.33003/fjs-2026-1013-5659
Resistência bacteriana e o uso indiscriminado de antibióticos na atenção primária
Paião, M. D. M., da Silva, T. D. S., Casarin, E. D., & Barros, R. R. (2026) · Revista fisio&terapia. · doi:10.69849/5bx0wq97
Bîrluțiu, V., & Bîrluţiu, R. M. (2026) · Microorganisms · doi:10.3390/microorganisms14091951
Utami, Y., Widyasanti, N. W. H., Sudipa, P. H., Besung, I. N. K., Sinambela, G. F., Rosaline, B. M., & Senduk, S. S. S. (2026) · Jurnal Sain Veteriner · doi:10.22146/jsv.114036
Wang, X., & Kong, N. (2026) · Microorganisms · doi:10.3390/microorganisms14092066
Wang, Q., Liu, Y., Zhu, Y., Luo, T., Sun, S., Ren, S., Li, X., Zhang, Y., Ren, L., Zhang, H., et al. (2026) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2026.125117
Smirnova, A. A., Fursova, K. K., Sokolov, S. L., Шерман, Д. К., Artemyeva, O. A., Kolodina, E., Dzhelyadin, T., Romanova, V. V., Brovko, F. A., & Nikanova, D. A. (2026) · Achievements of Science and Technology in Agro-Industrial Complex · doi:10.53859/02352451_2026_40_7_79
Magnan, C., Curtil-Dit-Galin, M., Morsli, M., Cattoir, V., Piau, C., Söderquist, B., Kahl, B. C., Denis, O., Rwayane, K., Corvec, S., et al. (2026) · Emerging Microbes & Infections · doi:10.1080/22221751.2026.2724635
Jasim, H. H., Gholami, M., Ahanjan, M., Ebrahimzadeh, M. A., & Goli, H. R. (2026) · International Microbiology · doi:10.1007/s10123-026-00898-x
Ghasemi, R., & Heidari, H. (2026) · Infectious Diseases and Therapy · doi:10.1007/s40121-026-01448-8
Chen, R., Guo, L.-Y., Deng, Y., Zhuang, Y., Cheng, Y., & Xu, Y. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.00547-26
Role of Lipid Nanoparticulate Carriers in the Management of Infectious Inflammatory Disorders
Rout, B., Gomte, S. S., Maharana, S. K., Devaraj, & Jain, A. (2026) · Wiley eBooks · doi:10.1002/9781394338832.ch8
Thiazole hybrids with antibacterial potential against Staphylococcus aureus
YIMEN, C. (2026) · Revue Roumaine de Chimie · doi:10.33224/rrch.2026.71.5-6.01
Threedeach, S., Moungsree, S., Thummakul, D., Netchu, K., & Suwanprapa, M. (2025) · Princess of Naradhiwas University Journal
In Vitro Antimicrobial Activity of Peperomia Pellucida Extract against Staphylococcus Epidermidis
Sukri, M. A. M. (2025) · Asian Journal of Medicine and Biomedicine · doi:10.37231/ajmb.2025.9.2.828
González, R. M. (2026) · Repositorio Digital de la UNC (National University of Cordoba)
Surekha K. Chavan, G. K. (2025) · South Eastern European Journal of Public Health
Silvola, J. (2026) · UTUPub (University of Turku)
Metadata
- Authors
- Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W.
- Affiliations
- Department of Dermatology, Immunodermatology and Venereology, Medical University of Warsaw, Koszykowa 82a, 02-008 Warsaw, Poland
- Academy of Face Sculpting, Jana Kazimierza 11B, 01-248 Warsaw, Poland
- Corresponding author
- Marusza, Wojciech
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-07-22
- Volume
- 23
- Issue
- 15
- Pages
- 8088
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9332259
- OpenAlex
- W4286587477
- Cited by
- 412
- References
- 242
- Citations by year
- 2026: 103 · 2025: 122 · 2024: 114 · 2023: 59 · 2022: 13
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Staphylococcus aureus, antibiotic resistance, methicillin-resistant Staphylococcus aureus, beta-lactam resistance, mec gene, glycopeptide resistance, vancomycin resistance, oxazolidinone resistance, linezolid, aminoglycoside resistance, fluoroquinolone resistance, tetracycline resistance, mupirocin resistance, fusidic acid resistance, daptomycin resistance, molecular epidemiology, virulence genes
- MeSH terms
- Aminoglycosides, Anti-Bacterial Agents, Drug Resistance, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.